Literature DB >> 18473926

Discovery-based strategies for studying platelet function.

R Flaumenhaft1, J R Dilks.   

Abstract

The platelet is an anucleate cell, complicating efforts to study platelet function by traditional genetic means. Discovery-based strategies have lead to the identification of pharmacological agents capable of targeting specific proteins critical for platelet activation. This review will address the evolution of discovery-based strategies to identify probes that are at once useful reagents for studying platelet activation and effective therapeutics.

Mesh:

Substances:

Year:  2008        PMID: 18473926     DOI: 10.2174/138955708783955971

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  2 in total

Review 1.  Antiplatelet therapies for the treatment of cardiovascular disease.

Authors:  Alan D Michelson
Journal:  Nat Rev Drug Discov       Date:  2010-02       Impact factor: 84.694

2.  Discovery of 1,3-Diaminobenzenes as Selective Inhibitors of Platelet Activation at the PAR1 Receptor.

Authors:  Chris Dockendorff; Omozuanvbo Aisiku; Lynn Verplank; James R Dilks; Daniel A Smith; Susanna F Gunnink; Louisa Dowal; Joseph Negri; Michelle Palmer; Lawrence Macpherson; Stuart L Schreiber; Robert Flaumenhaft
Journal:  ACS Med Chem Lett       Date:  2012-01-30       Impact factor: 4.345

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.